{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T17:35:16Z","timestamp":1780594516668,"version":"3.54.1"},"reference-count":14,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100008385","name":"Fondazione per La Ricerca sulla Fibrosi Cistica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008385","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.jcf.2023.04.012","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T18:54:36Z","timestamp":1682103276000},"page":"680-682","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["The combination elexacaftor\/tezacaftor\/ivacaftor (ETI) modulates the de novo synthethic pathway of ceramides in a genotype-independent manner"],"prefix":"10.1016","volume":"22","author":[{"given":"Nara","family":"Liessi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3761-1916","authenticated-orcid":false,"given":"Valeria","family":"Tomati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9740-1171","authenticated-orcid":false,"given":"Valeria","family":"Capurro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2741-7418","authenticated-orcid":false,"given":"Nicoletta","family":"Loberto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1330-6610","authenticated-orcid":false,"given":"Mar","family":"Garcia-Aloy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5711-4429","authenticated-orcid":false,"given":"Pietro","family":"Franceschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1916-2440","authenticated-orcid":false,"given":"Massimo","family":"Aureli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Pedemonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3766-8755","authenticated-orcid":false,"given":"Andrea","family":"Armirotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"28","key":"10.1016\/j.jcf.2023.04.012_bib0001","doi-asserted-by":"crossref","first-page":"25512","DOI":"10.1074\/jbc.M202947200","article-title":"Identification and characterization of a sphingolipid delta 4-desaturase family","volume":"277","author":"Ternes","year":"2002","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.jcf.2023.04.012_bib0002","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1165\/rcmb.2007-0036OC","article-title":"Fenretinide corrects newly found ceramide deficiency in cystic fibrosis","volume":"38","author":"Guilbault","year":"2008","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"10.1016\/j.jcf.2023.04.012_bib0003","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1165\/rcmb.2008-0279OC","article-title":"Cystic fibrosis fatty acid imbalance is linked to ceramide deficiency and corrected by fenretinide","volume":"41","author":"Guilbault","year":"2009","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"16","key":"10.1016\/j.jcf.2023.04.012_bib0004","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.138722","article-title":"Distinctive lipid signatures of bronchial epithelial cells associated with cystic fibrosis drugs, including Trikafta","volume":"5","author":"Liessi","year":"2020","journal-title":"JCI Insight"},{"issue":"17","key":"10.1016\/j.jcf.2023.04.012_bib0005","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1007\/s00216-015-8585-6","article-title":"Rapid evaluation of 25 key sphingolipids and phosphosphingolipids in human plasma by LC-MS\/MS","volume":"407","author":"Basit","year":"2015","journal-title":"Anal Bioanal Chem"},{"issue":"43","key":"10.1016\/j.jcf.2023.04.012_bib0006","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.21105\/joss.01686","article-title":"Welcome to the Tidyverse","volume":"4","author":"Wickham","year":"2019","journal-title":"Journal of Open Source Software"},{"issue":"10","key":"10.1016\/j.jcf.2023.04.012_bib0007","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/nbt.2377","article-title":"A cross-platform toolkit for mass spectrometry and proteomics","volume":"30","author":"Chambers","year":"2012","journal-title":"Nature Biotechnology"},{"issue":"3","key":"10.1016\/j.jcf.2023.04.012_bib0008","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1021\/ac051437y","article-title":"XCMS:\u2009 Processing Mass Spectrometry Data for Metabolite Profiling Using Nonlinear Peak Alignment, Matching, and Identification","volume":"78","author":"Smith","year":"2006","journal-title":"Analytical Chemistry"},{"issue":"18","key":"10.1016\/j.jcf.2023.04.012_bib0009","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1093\/bioinformatics\/btv299","article-title":"Fast parametric time warping of peak lists","volume":"31","author":"Wehrens","year":"2015","journal-title":"Bioinformatics"},{"issue":"14","key":"10.1016\/j.jcf.2023.04.012_bib0010","doi-asserted-by":"crossref","first-page":"6812","DOI":"10.1021\/ac501530d","article-title":"RAMClust: a novel feature clustering method enables spectral-matching-based annotation for metabolomics data","volume":"86","author":"Broeckling","year":"2014","journal-title":"Anal Chem"},{"issue":"9","key":"10.1016\/j.jcf.2023.04.012_bib0011","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1194\/jlr.P094433","article-title":"Rare DEGS1 variant significantly alters de novo ceramide synthesis pathway","volume":"60","author":"Blackburn","year":"2019","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jcf.2023.04.012_bib0012","unstructured":"https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/kaftrio."},{"issue":"11","key":"10.1016\/j.jcf.2023.04.012_bib0013","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1038\/s41431-019-0444-z","article-title":"DEGS1 variant causes neurological disorder","volume":"27","author":"Dolgin","year":"2019","journal-title":"European Journal of Human Genetics"},{"issue":"3","key":"10.1016\/j.jcf.2023.04.012_bib0014","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1172\/JCI124159","article-title":"DEGS1-associated aberrant sphingolipid metabolism impairs nervous system function in humans","volume":"129","author":"Karsai","year":"2019","journal-title":"J Clin Invest"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199323001157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199323001157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T22:07:11Z","timestamp":1762553231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199323001157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S1569199323001157"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2023.04.012","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The combination elexacaftor\/tezacaftor\/ivacaftor (ETI) modulates the de novo synthethic pathway of ceramides in a genotype-independent manner","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2023.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Cystic Fibrosis Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}